This meta-analysis separates oral from intralesional corticosteroid comparators for the first time, giving pediatric pharmacists route-specific context for propranolol-first prescribing in infantile haemangioma (IH).
📅 Journal publication: Oct 28, 2026·Last updated: Nov 5, 2026
Propranolol outperforms corticosteroids in treating infantile haemangiomas.
Infantile haemangiomas are common vascular tumors in infants, and treatment choices can impact outcomes and safety. Propranolol had higher treatment effectiveness than corticosteroids (OR: 4.96) and fewer adverse events (OR: 0.27). Propranolol is more effective and safer than oral corticosteroids for IH, but intralesional corticosteroids may be considered based on lesion characteristics. Propranolol is favored over corticosteroids for infantile haemangiomas due to better efficacy and safety.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Sato A, Burns JWF, Sivanesan K, Haysom R, Riese D, Ghotra E, Chua KR, Lee SC, Nakanishi H, Than CA, Wong KY
Citation:Sato A, Burns JWF, Sivanesan K, et al. Comparative Outcomes of Propranolol and Corticosteroids in Infantile Haemangiomas: A Systematic Review and Meta-Analysis. British journal of hospital medicine (London, England : 2005). 2026;87(10):54357. doi:10.31083/BJHM54357